Zum Inhalt

Journal of Cancer Research and Clinical Oncology

Ausgabe 1/2026

Inhalt (38 Artikel)

Research progress on ferroptosis in drug resistance and therapy of gastric cancer

  • Open Access
  • Review

Yuexin Liu, Lizhou Jia, Liu Yang, Zhang Ning, Yanmei Li

The c.1744G > C, p.(Glu582Gln) missense variant in coding exon 14 of APC increases skipping of a natural occurring isoform and causes Familial Adenomatous Polyposis

  • Open Access
  • Correspondence

Anne Marie Jelsig, Maria Bejerholm Boelman, Ulf Birkedal, Jane Hübertz, Lana Al-Zehawi, Charlotte Lautrup, John Gásdal Karstensen, Thomas van Overeem Hansen

TKI plus ICI versus ICI alone in high tumor burden hepatocellular carcinoma: a retrospective cohort study

  • Open Access
  • Research

Po-Ting Lin, Wei Teng, Wei-Ting Chen, Chung-Wei Su, Yi-Chung Hsieh, Chen-Chun Lin, Chun-Yen Lin, Shi-Ming Lin

157Gd-DHK: enhancing targeted gadolinium neutron capture for pancreatic adenocarcinoma

  • Open Access
  • Research

Liang Xie, Cuiping Song, Jialin Qin, Qianqian Xu, Jianchun Yin, Yuanyuan Ma, Hong Chen, Chao Li, Bing Hong, Ni Chen, Xiaoxi Pang

Concept and feasibility of privacy-preserving record linkage of cancer registry data and claims data in Germany: results from the DigiNet study on stage IV non-small cell lung cancer

  • Open Access
  • Research

Anika Kästner, Christopher Hampf, Pia Naumann, Lizon Fiedler-Lacombe, Anna Kron, Anna Spier, Dusan Simic, Leonie Eilers, Aleksandra Graw, Sebastian Bartholomäus, Andreas Stang, Daniela Reil, Renate Kirschner-Schwabe, Jessica Isabel Selig, Jörg Wulff, Patrik Dröge, Thomas Ruhnke, Christian Günster, Uwe Nußbaum, Ursula Marschall, Juliane Mohnke, Anja Hebbelmann, Uwe Lührig, Anna Rasokat, Vanessa Mildenberger, Stephanie Stock, Florian Kron, Jürgen Wolf, Martin Bialke, Dana Stahl, Neeltje van den Berg, Wolfgang Hoffmann

Impact of preoperative geriatric screening and comorbidity assessment in patients with vulvar and vaginal cancer

  • Open Access
  • Research

Valerie Catherine Linz, Emma Liebau, Markus Schepers, Katharina Gillen, Marco Johannes Battista, Michael Mohr, Mona Wanda Schmidt, Marcus Schmidt, Annette Hasenburg

​Hematological parameters as predictors of oral cancer prognosis: a systematic review and meta-analysis

  • Open Access
  • Review

Abdullah M. Alshahrani, Kanwalpreet Kaur, Ravinder S. Saini, Artak Heboyan

Comprehensive analysis based on spatial domains identifies CD44 as a potential target of puerarin

  • Open Access
  • Research

Song-yang Xi, Hui Zhang, Qi-juan Wang, Yuan-jie Liu, Shu-chen Chang, Chen-fu Shi, Dong Fang, Li-hui-ping Tao, Hai-bo Cheng, Xi Zou

Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer center

  • Open Access
  • Research

Niklas Amann, Manuel Hörner, Henrik Spannring, Lena Brückner, Julia Gocke, Carolin Müller, Cornelia Boesl, Simon Bader, Felix Heindl, Carolin C. Hack, Peter A. Fasching, Matthias W. Beckmann, Annika Krückel

Unveiling hidden players: the role of intratumoral microbiota in gastrointestinal cancer dynamics

  • Open Access
  • Review

Wanfen Tang, Fakai Li, Hongjuan Zheng, Shishi Zhou, Chenhui Li, Xifeng Xu, Jianfei Fu

Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experience

  • Open Access
  • Research

Keitaro Shimozaki, Akira Ooki, Shota Fukuoka, Hiroki Osumi, Kaoru Yoshikawa, Koichiro Yoshino, Shohei Udagawa, Takeru Wakatsuki, Eiji Shinozaki, Mariko Ogura, Keisho Chin, Kensei Yamaguchi

Performance of large language models in reporting oral health concerns and side effects in head and neck cancer: a comparative study

  • Open Access
  • Research

Jonas Rast, Susanne Wiegand, Jana Biermann, Annette Wiegand, Felix Marschner

Brahmi (Bacopa monnieri) plant preparation facilitates to enhance the activities of dendritic cells to control non-small cell lung cancer (NSCLC)

  • Open Access
  • Research

R. Ilaya Kumar, Kavya Jain, Prashasti Arora, Harshnna Gururajan, Karan Raj Rai, Oishi Mukherjee, Melvin George, Koustav Sarkar

Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection

  • Open Access
  • Research

Gianella Cornejo, Alon Pikarsky, Ayala Hubert, Marc Wygoda, Antoni Skripai, Aron Popovtzer, Jon Feldman, Yair Hillman, Liat Appelbaum, Mark Temper, Abed Khalaileh, Ashraf Imam, Gideon Zamir, Philip Blumenfeld

Extracellular vesicles-derived non-coding RNA in leukemias and pre-leukemic syndromes: a systematic review

  • Open Access
  • Review

Narjes Seddighi, Malihe Najafpour, Mohammadreza Riyahi, Sepideh Mahmoudzadeh, Mehdi Talebi

Impact of comorbidities on treatment management and prognosis in patients with anaplastic thyroid cancer (ATC)

  • Open Access
  • Research

Teresa Augustin, Dmytro Oliinyk, Marlen Haderlein, Charlotte Frei, Julia Jacob, Daniel Medenwald, Maike Trommer, Matthias Mäurer, Sonia Drozdz, Alexander Rühle, Anca-Ligia Grosu, Nils Henrik Nicolay, Maria Waltenberger, Stephanie E. Combs, Anastassia Löser, Michael Oertel, Hans Theodor Eich, Stefan Janssen, Josefine Rauch, Ralph Gurtner, Robert Renollet, Christine Spitzweg, Dirk Vordermark, Claus Belka, Lukas Käsmann

The protective effect of probiotic therapy on gut microbiota and the activation of ω-oxidation after ovarian cancer surgery

  • Open Access
  • Research

Chen Geng, Qingling Cao, Zhuo Chen, Xiaoyan Song, Xiaoyuan Shi

Correction: Prediction models for different types of leukemia: a systematic review and critical appraisal

  • Open Access
  • Correction

Ayizhati Tuerxun, Yingzi Yang, Xinqi Cai, Xinyu Chen, Zhuoya Zhao, Yang Zhao, Zinuo Lin, Shengfeng Wang

Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanoma

  • Open Access
  • Research

Jonathan S. Zager, Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J. Eschelman, Evan S. Glazer, Aslam Ejaz, Erika Richtig, Sebastian Ochsenreither, Sunil A. Reddy, Michael C. Lowe, Georgia M. Beasley, Anja Gesierich, Martin Gschnell, Reinhard Dummer, Ana Arance, Stephen William Fenwick, Joseph J. Sacco, Johnny John, Matthew Wheater, Christian H. Ottensmeier

Retraction Note: High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence

  • Open Access
  • Retraction Note

Mukta Basu, Amvrin Chatterjee, Balarko Chakraborty, Essha Chatterjee, Sabnam Ghosh, Sudip Samadder, Dilip Kumar Pal, Anup Roy, Jayanta Chakrabarti, Amlan Ghosh, Chinmay Kumar Panda

Correction: The positive feedback loop of MAD2L1/TYK2/STAT3 induces progression in B-cell acute lymphoblastic leukaemia

  • Open Access
  • Correction

Liwen Zhu, Xinyu Li, Diandian Liu, Wenke Bai, Huaqing Yang, Qianyi Cheng, Luhong Xu, Jianpei Fang

Harnessing early postoperative MRD and VAF dynamics for precision prognosis in resected colorectal liver metastases

  • Open Access
  • Research

Peisi Li, Tuoyang Li, Mingzhe Huang, Yiting Liu, Peiji Liu, Yuanhui Wu, Xuan Li, Rongzhao He, Yingguo Gan, Yisong Hong, Puning Wang, Jinxin Lin, Meijin Huang

Profiling and functional analysis of exosomal circRNAs from EBV-associated gastric carcinoma CSCs

  • Open Access
  • Research

Li-ping Gong, Yi-ting Shao, Yu Du, Li-ping Sun, Lu-ying Tang, Jian-ning Chen

Total neoadjuvant therapy for locally advanced rectal cancer: barriers to implementation in real-world practice

  • Open Access
  • Research

David Rene Steike, Niklas Benedikt Pepper, Stefan Gravemeyer, Anne Bremer, Bernhard Glasbrenner, Matthias Brüwer, Andreas Pascher, Dirk Domagk, Lothar Biermann, Philipp Lenz, Hans Theodor Eich, Gabriele Reinartz

AI-MDT: an automatic and intelligent multidisciplinary team consultations platform for lung cancer diagnosis

  • Open Access
  • Research

Yunyou Liu, Fei Wang, Peng Wang, Zhen Zhou, Hongqian Wang, Jingyao Li, Yang Qiu, Haidong Wang, Siwei Miao

Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma

  • Open Access
  • Research

Sila Oksuz, Oguzcan Kinikoglu, Ugur Ozkerim, Deniz Isik, Heves Surmeli, Seval Ay, Utku Donem Gundogdu, Tugba Basoglu, Hatice Odabas, Nedim Turan

Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis

  • Open Access
  • Research

Michael Hoberger, Romy L. Zuber, Anton Burkhard-Meier, Dorit Di Gioia, Vindi Jurinovic, Michael Völkl, Sinan E. Güler, Markus Albertsmeier, Alexander Klein, Hans Roland Dürr, Nina-Sophie Schmidt-Hegemann, Thomas Knösel, Wolfgang G. Kunz, Michael von Bergwelt-Baildon, Lars H. Lindner, Luc M. Berclaz

Type I-interferon β induces a strong anti-tumour response in bladder cancer cells

  • Open Access
  • Research

Marlena Hesse, Max Iltzsche, Daniel Nahhas, Christian Thomas, Susanne Füssel, Barbara Kind

Hypoalbuminemia as a prognostic marker for survival in biliary tract cancer: associations with tumor type, treatment and sex

  • Open Access
  • Research

Mostafa Abdulrazzak, Linda Björkhem-Bergman, Christina Villard, Marco Gerling, Tina Gustavell, Hannes Jansson

Neu im Fachgebiet Onkologie

Erhöht Reflux auch das Risiko für Larynxtumoren?

Gastroösophagealer Reflux ist womöglich auch mit einem erhöhten Risiko für Kehlkopftumoren assoziiert. Dafür sprechen zumindest Teilergebnisse einer aktuellen Metaanalyse. Im Detail ist der Zusammenhang indes weniger klar.

Viel Konservierungsstoffe in der Nahrung – erhöhtes Krebsrisiko

Wer viel Konservierungsstoffe über die Nahrung aufnimmt, muss mit einem erhöhten Krebsrisiko rechnen. Ein solcher Zusammenhang lässt sich primär für nicht antioxidativ wirkende Zusatzstoffe wie Nitrit und Nitrat, aber auch Sorbat und Acetat berechnen.

CAR-T-Zell-Infusion bei B-Zell-Lymphom möglichst am Vormittag?

Bei Menschen mit rezidivierendem großzelligem B-Zell-Lymphom ist das zirkadiane Timing einer CAR-T-Zell-Infusion möglicherweise entscheidend. In einer US-Studie wurde 22 Monate nachbeobachtet, wie sich die Tageszeit der Therapiegabe auf das progressionsfreie Überleben auswirkte.

AKT-Blocker verlängert PFS bei PTEN-defizientem mHSPC

Eine Zusatztherapie mit Capivasertib kann das radiologisch bestimmte progressionsfreie Überleben von Männern mit metastasiertem hormonsensitivem Prostatakarzinom deutlich verlängern. Im Vergleich zu Placebo wurde in einer Phase-3-Studie ein Vorteil von 7,5 Monaten erzielt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Würste und Spieße auf einem Grill/© NDABCREATIVITY / stock.adobe.com (Symbolbild mit Fotomodellen), Diffus großzelliges B-Zell-Lymphom/© David A Litman / stock.adobe.com, Mann nimmt Tablette zuhause ein/© Jelena Stanojkovic / stock.adobe.com (Symbolbild mit Fotomodell)